June 24 Single dose of 'magic mushrooms' provides 5 years of depression relief, researchers find The magic mushroom compound psilocybin shows long-lasting antidepressant effects in a clinical trial, with patients reporting less anxiety and improved daily functioning years later.
June 23 Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.
June 19 FDA approves first twice-yearly injection that prevents HIV infection The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly alternative to daily medications.
June 19 Your DNA could be stopping you from losing weight, new study suggests Genetic factors may explain why some people don't lose weight even when following nutritious diets, although health improvements can still be seen regardless of weight changes.
June 18 Weight-loss surgery trumps popular Ozempic treatment in shocking new comparison Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.
June 18 NSAIDs vs. acetaminophen: What you need to know before your next headache Doctors compare household painkillers like ibuprofen and acetaminophen, explaining their mechanisms and when each works best for pain and inflammation.
June 15 Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose Clinical trial shows Obicetrapib pill lowers bad cholesterol and lipoprotein(a) in high-risk patients on maximum cholesterol therapy, offering hope for treatment-resistant cases.
June 14 Hairstylists and medical expert confirm temporary hair loss affecting Ozempic users Experts discuss how weight loss can trigger temporary hair loss, with hairstylists and an endocrinologist providing insights on managing symptoms and hair regrowth.
June 10 First-known puberty blocker patient says 'insulting' youth gender movement makes mockery of true dysphoria The first patient to receive puberty blockers for gender dysphoria criticized the youth gender identity movement as "insulting" and a "fashion statement" in a New York Times interview.
June 10 Who should be taking weight-loss drugs? Doctors share best candidates GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.